CRISPR/Cas9 and gene therapy

The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Giono, L.E.
Formato:	JOUR
Materias:	CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	todo:paper_00257680_v77_n5_p405_Giono
record_format	dspace
spelling	todo:paper_00257680_v77_n5_p405_Giono2023-10-03T14:36:49Z CRISPR/Cas9 and gene therapy Giono, L.E. CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defense mechanism that has been redesigned for its use in other cellular systems. The accessibility, both technical and economical, and the enormous potential of CRISPR/Cas9 have contributed to an almost unprecedented revolution in the biomedical sciences and represent an important step forward in the field of gene therapy that needs, however, to be taken cautiously. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing
spellingShingle	CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing Giono, L.E. CRISPR/Cas9 and gene therapy
topic_facet	CRISPR/Cas9 gene therapy genome editing human embryos animal CRISPR Cas system gene editing gene therapy genetic engineering genetics human RNA editing Animals CRISPR-Cas Systems Gene Editing Genetic Engineering Genetic Therapy Humans RNA Editing
description	The development of techniques that allow the precise and efficient edition of the genome of living cells is one of the main goals of biomedical research. Over the last few decades, a number of genome editing tools have been developed, the most prominent being the CRISPR/Cas9 system, a bacterial defense mechanism that has been redesigned for its use in other cellular systems. The accessibility, both technical and economical, and the enormous potential of CRISPR/Cas9 have contributed to an almost unprecedented revolution in the biomedical sciences and represent an important step forward in the field of gene therapy that needs, however, to be taken cautiously.
format	JOUR
author	Giono, L.E.
author_facet	Giono, L.E.
author_sort	Giono, L.E.
title	CRISPR/Cas9 and gene therapy
title_short	CRISPR/Cas9 and gene therapy
title_full	CRISPR/Cas9 and gene therapy
title_fullStr	CRISPR/Cas9 and gene therapy
title_full_unstemmed	CRISPR/Cas9 and gene therapy
title_sort	crispr/cas9 and gene therapy
url	http://hdl.handle.net/20.500.12110/paper_00257680_v77_n5_p405_Giono
work_keys_str_mv	AT gionole crisprcas9andgenetherapy
_version_	1807318319592636416

CRISPR/Cas9 and gene therapy

Ejemplares similares